Divi's Laboratories Limited (DIVISLAB.BO)
INR 5849.2
(0.02%)
INR 5849.2
(0.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.17 Billion INR | -45.19% |
| 2022 | 25.85 Billion INR | 14.47% |
| 2021 | 22.58 Billion INR | 17.73% |
| 2020 | 19.18 Billion INR | 24.42% |
| 2019 | 15.41 Billion INR | 21.58% |
| 2018 | 12.68 Billion INR | 10.58% |
| 2017 | 11.46 Billion INR | -0.72% |
| 2016 | 11.55 Billion INR | 20.32% |
| 2015 | 9.59 Billion INR | 11.26% |
| 2014 | 8.62 Billion INR | 25.31% |
| 2013 | 6.88 Billion INR | 13.64% |
| 2012 | 6.05 Billion INR | 28.4% |
| 2011 | 4.71 Billion INR | 77.74% |
| 2010 | 2.65 Billion INR | 6.05% |
| 2009 | 2.5 Billion INR | 14.45% |
| 2008 | 2.18 Billion INR | 51.42% |
| 2007 | 1.44 Billion INR | 4.42% |
| 2006 | 1.38 Billion INR | 90.96% |
| 2005 | 724.41 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.5 Billion INR | -21.72% |
| 2023 Q3 | 7.32 Billion INR | 2.38% |
| 2023 FY | 14.17 Billion INR | -45.19% |
| 2023 Q2 | 7.15 Billion INR | 5.3% |
| 2023 Q1 | 6.79 Billion INR | 10.53% |
| 2023 Q4 | 3.73 Billion INR | -49.04% |
| 2022 Q3 | 6.46 Billion INR | 0.25% |
| 2022 FY | 25.85 Billion INR | 14.47% |
| 2022 Q1 | 6.79 Billion INR | 37.88% |
| 2022 Q2 | 6.45 Billion INR | -5.01% |
| 2022 Q4 | 6.14 Billion INR | -5.0% |
| 2021 Q2 | 5.91 Billion INR | 9.68% |
| 2021 Q3 | 6.44 Billion INR | 8.86% |
| 2021 Q4 | 4.92 Billion INR | -23.58% |
| 2021 FY | 22.58 Billion INR | 17.73% |
| 2021 Q1 | 5.39 Billion INR | 24.35% |
| 2020 FY | 19.18 Billion INR | 24.42% |
| 2020 Q4 | 4.34 Billion INR | -21.34% |
| 2020 Q3 | 5.51 Billion INR | 11.92% |
| 2020 Q2 | 4.93 Billion INR | 10.36% |
| 2020 Q1 | 4.46 Billion INR | 20.27% |
| 2019 FY | 15.41 Billion INR | 21.58% |
| 2019 Q3 | 4.01 Billion INR | -1.32% |
| 2019 Q2 | 4.07 Billion INR | 10.9% |
| 2019 Q4 | 3.71 Billion INR | -7.58% |
| 2019 Q1 | 3.67 Billion INR | 48.51% |
| 2018 Q1 | 3.15 Billion INR | 0.0% |
| 2018 FY | 12.68 Billion INR | 10.58% |
| 2018 Q4 | 2.47 Billion INR | -37.53% |
| 2018 Q3 | 3.95 Billion INR | 12.24% |
| 2018 Q2 | 3.52 Billion INR | 11.76% |
| 2017 FY | 11.46 Billion INR | -0.72% |
| 2016 FY | 11.55 Billion INR | 20.32% |
| 2015 FY | 9.59 Billion INR | 11.26% |
| 2014 Q4 | 2.39 Billion INR | 0.0% |
| 2014 FY | 8.62 Billion INR | 25.31% |
| 2013 Q4 | 1.9 Billion INR | 0.0% |
| 2013 FY | 6.88 Billion INR | 13.64% |
| 2012 Q4 | 1.59 Billion INR | 0.0% |
| 2012 FY | 6.05 Billion INR | 28.4% |
| 2011 FY | 4.71 Billion INR | 77.74% |
| 2010 FY | 2.65 Billion INR | 6.05% |
| 2009 FY | 2.5 Billion INR | 14.45% |
| 2008 FY | 2.18 Billion INR | 51.42% |
| 2007 FY | 1.44 Billion INR | 4.42% |
| 2006 FY | 1.38 Billion INR | 90.96% |
| 2005 FY | 724.41 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ajanta Pharma Limited | 30.46 Billion INR | 53.484% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -1189.368% |
| Sigachi Industries Limited | 579.88 Million INR | -2343.58% |
| Bal Pharma Limited | 389.89 Million INR | -3534.358% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -567.08% |
| Medico Remedies Limited | 161.84 Million INR | -8655.345% |
| Lasa Supergenerics Limited | 291.17 Million INR | -4766.506% |
| Venus Remedies Limited | 1.91 Billion INR | -639.452% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -360.543% |
| Alpa Laboratories Limited | 156.14 Million INR | -8974.782% |
| Nectar Lifesciences Limited | 625.55 Million INR | -2165.207% |
| Shilpa Medicare Limited | 2.18 Billion INR | -549.824% |
| Aarti Drugs Limited | 1.16 Billion INR | -1113.726% |
| Lupin Limited | 95.67 Billion INR | 85.189% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 63.884% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 67.179% |
| Windlas Biotech Limited | 1 Billion INR | -1307.835% |
| Suven Life Sciences Limited | 109.75 Million INR | -12811.162% |
| Eris Lifesciences Limited | 4.94 Billion INR | -186.671% |
| Valiant Laboratories Limited | 36.28 Million INR | -38947.645% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -68.348% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -209.409% |
| Ipca Laboratories Limited | 13.91 Billion INR | -1.833% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -898.434% |
| Achyut Healthcare Limited | 1.6 Million INR | -880571.224% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 90.81% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1338.075% |
| RPG Life Sciences Limited | 1.63 Billion INR | -766.402% |
| Mankind Pharma Limited | 23.15 Billion INR | 38.798% |
| Laurus Labs Limited | 3.01 Billion INR | -370.639% |
| Piramal Pharma Limited | 19.91 Billion INR | 28.844% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -1403.609% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 33.853% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 10.71% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 79.027% |
| Unichem Laboratories Limited | 6.72 Billion INR | -110.679% |
| Sequent Scientific Limited | 2.9 Billion INR | -388.316% |
| Novartis India Limited | 470.1 Million INR | -2914.252% |
| Wanbury Limited | 1.16 Billion INR | -1120.576% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -910.131% |
| Wockhardt Limited | 6.4 Billion INR | -121.406% |
| Themis Medicare Limited | 782.85 Million INR | -1710.041% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -1732.146% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 1.965% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -21.728% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 85.221% |
| NATCO Pharma Limited | 10.05 Billion INR | -40.883% |
| Gufic Biosciences Limited | 1.07 Billion INR | -1214.824% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -1189.589% |
| Ind-Swift Limited | 946.56 Million INR | -1396.989% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -373.059% |
| FDC Limited | 5.34 Billion INR | -164.933% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -30600.234% |
| Granules India Limited | 7.18 Billion INR | -97.289% |
| Medicamen Biotech Limited | 335.16 Million INR | -4127.743% |
| Alkem Laboratories Limited | 32.83 Billion INR | 56.845% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -444.916% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -87316.799% |
| Brooks Laboratories Limited | 51.18 Million INR | -27586.596% |
| Megasoft Limited | 49.52 Million INR | -28510.08% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1298.735% |
| Strides Pharma Science Limited | 9.16 Billion INR | -54.655% |
| Neuland Laboratories Limited | 2.92 Billion INR | -383.66% |
| Morepen Laboratories Limited | 1.98 Billion INR | -612.974% |
| Hikal Limited | 2.48 Billion INR | -469.914% |
| Indoco Remedies Limited | 4.74 Billion INR | -198.393% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -360.903% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -3335.76% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -1995.698% |
| Hester Biosciences Limited | 908.84 Million INR | -1459.13% |